Tumor necrosis factor-α-induced accumulation of tumor suppressor protein p53 and cyclin-dependent protein kinase inhibitory protein p21 inhibited by insulin in ME-180S cells

Clinical Chemistry and Laboratory Medicine

Volumn 40, Issue 8, 2002, Pages 764-768

  Akca, Hakan ^a   Yenisoy, Selma ^a   Yanikoglu, Atila ^a   Ozes, Osman Nidai ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Apoptosis; Insulin; ME 180S cells; p21; p53; TNF

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; GROWTH FACTOR; INSULIN; PROTEIN P21; PROTEIN P53; TUMOR NECROSIS FACTOR ALPHA; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; TUMOR SUPPRESSOR PROTEIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CARCINOMA CELL; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CARCINOMA; BIOSYNTHESIS; CELL CULTURE; CELL DIVISION; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; PATHOLOGY; PHYSIOLOGY; UTERINE CERVIX TUMOR;

APOPTOSIS; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INSULIN; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; UTERINE CERVICAL NEOPLASMS;

EID: 0036380785     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2002.131     Document Type: Article

References (28)

1. Lewis M, Tartaglia LA, Lee A, Bennett GL, Rice GC, Wong GH, et al. Cloning and expression of cDNAs fort two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc Natl Acad Sci 1991; 88:2830-4.
2. Smith CA, Davis T, Anderson D, Solam L, Beckmann MP, Jerzy R, et al. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 1990; 248:1019-23.
3. Bacer SJ, Reddy EP. Modulation of life and death by the TNF receptor superfamily. Oncogene 1998; 17:3261-70.
4. Nagata S. Apoptosis by death factor. Cell 1997; 88:355-65.
5. Linzer DI, Levine AJ. Characterization of a 54 K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell 1979; 17:43-52.
6. Oren M, Levine AJ. Molecular cloning of a cDNA specific for the murine p53 cellular tumor antigen. Proc Natl Acad Sci 1983; 80:56-9.
7. Michael HC, Kubbutat MH, Vousden KH. Keeping an old friend under control: regulation of p53 stability. Mol Med Today 1998; 4:250-6.
8. Bates S, Vousden KH. P53 signaling checkpoint arrest or apoptosis. Curr Opin Genet Dev 1996; 6:12-8.
9. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, et al. WAF1, potential mediator of p53 tumor suppression. Cell 1993; 75:817-25.
10. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994; 9:1799-805.
11. Okomato K, Beach D. Cyclin G is a transcriptional target of the p53 tumor suppressor protein. EMBO J 1994; 13:4816-22.
12. Barak Y, Juven T, Haffner R, Oren M. Mdm2 expression is induced by wild type p53 activity. EMBO J 1993; 12:461-8.
13. Deng C, Zang P, Harper JW, Elledge SJ, Leder P. Mice lacking p2l Cip/waf1 undergo normal development but are defective in G1 checkpoint control. Cell 1995; 82:675-84.
14. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D. p21 is a universal inhibitor of cyclin kinases. Nature 1993; 366:701-4.
15. Chao DT, Kormeyer SJ. BCL-2 family regulators of cell death. Annu Rew Immunol 1998; 16:365-419.
16. Cheatham B, Kahn CR. Insulin action and the insulin signaling network. Endocrin Rev 1995; 16:117-42.
17. Barber AJ, Nakamura M, Wolpert EB, Reiter CE, Seigel GM, Antonetti DA, et al. Insulin rescues retinal neurons from apoptosis by a phosphatidylinositol 3-kinase/AKT-mediated mechanism that reduces the activation of caspase-3. Biol Chem 2001; 276:32814-21.
18. Bonnet MMR, Garrouste FL, Heller S, Andre F, Marvaldi JL, Pommier GJ. Insulin-like growth factor I protects colon cancer cells from death factor-induced apoptosis by potentiating tumor necrosis factor-α-induced mitogen-activated protein kinase and nuclear factor κB signalling pathways. Cancer Res 2000; 60:2007-17.
19. . Parrizas M, Saltiel AR, Leroith D. Insulin-like growth factor I inhibits apoptosis using the phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways. J Biol Chem 1997; 272:154-61.
20. Prisco M, Romano G, Peruzzi F, Valentinis B, Baserga R. Insulin and IGF-I receptor signalling in protection from apoptosis. Horm Met Res 1999; 31:80-9.
21. Sherr CJ, Roberta JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999; 13:1501-12.
22. Sugiyama H, Savill JS, Kitamura M, Zhao L, Stylianou E. Selective sensitization to tumor necrosis factor-α-induced apoptosis by blockade of NF-κB in primery glomerular mesangial cells. J Biol Chem 1999; 274:19532-7.
23. Scheid MP, Woodget JR. PKB/AKT. functional insights from genetic models. Nat Rev Mol Cell Biol 2001; 2:760-8.
24. Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB. NF-κB activation by tumor necrosis factor requires the Akt serine-threonine kinase. Nature 199; 401:82-5.
25. Romashkova JA, Makarov SS. NF-κB is a target of Akt in anti-apoptotic PDGF signaling. Nature 1999; 401:86-90
26. Mayo DL, Donner DB. A phosphatidylinositol 3-kinase/AKT pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus. Proc Natl Acad Sci USA 2001; 98:11598-603.
27. Webster GA, Perkins ND. Transcriptional cross talk between NF-κB and p53. Mol Cell Biol 1999; 19:3485-95.
28. Donato NJ, Perez M. Tumor necrosis factor-induced apoptosis stimulates p53 accumulation and p21/WAF1 proteolysis in ME-180S cells. J Biol Chem 1998; 273:5067-72.